CDH1 and neoplasm: Furthermore, the rate of CDH1 methylation was 63.0% in GC tissues from the patient in stage I/II, which is much lower than that in stage I/II (100.0%) (P < 0.05), it is showed CDH1 methylation may be used in evaluating the malignant degree of the tumor.